RE:RE:You Don't Want To Talk Covid19 & Oil? STF Then And Scroll On Thanks. yes data suggested hospitalizations we're reduced and also why Pfizer 1st and only choice for many.
but now from what I understand it's come to light clinical trails for Pfizer revealed made no difference in deaths from those with the placebo. I'll look for the link for you. Scientists recently banned off Twitter for discussing... ended up on Fox/Tucker Carlson I think?
And now transmission and virus cases the same as unvaccinated so it seems they have a huge PR issue in front of them. That's why everyone including vaxxers now have to wear masks again. Lol so what's next is my question.
the way the numbers and cases are being counted appear to be criminal overall.
Australia PM out of his mind imo.
ManitobaCanuck wrote:
Dear Snowballer
Please see this research article from NEJM.
This shows Pfizer vaccine is 90% effective against delta variant . The delta variant maybe more infectious/transmissible but does not cause more severe disease or possibly more virulent than alpha variant.
https://www.nejm.org/doi/full/10.1056/NEJMoa2108891
RESULTS
Effectiveness after one dose of vaccine (BNT162b2 or ChAdOx1 nCoV-19) was no- tably lower among persons with the delta variant (30.7%; 95% confidence interval [CI], 25.2 to 35.7) than among those with the alpha variant (48.7%; 95% CI, 45.5 to 51.7); the results were similar for both vaccines. With the BNT162b2 vaccine, the effectiveness of two doses was 93.7% (95% CI, 91.6 to 95.3) among persons with the alpha variant and 88.0% (95% CI, 85.3 to 90.1) among those with the delta variant. With the ChAdOx1 nCoV-19 vaccine, the effectiveness of two doses was 74.5% (95% CI, 68.4 to 79.4) among persons with the alpha variant and 67.0% (95% CI, 61.3 to 71.8) among those with the delta variant.
CONCLUSIONS
Only modest differences in vaccine effectiveness were noted with the delta variant as compared with the alpha variant after the receipt of two vaccine doses. Absolute differences in vaccine effectiveness were more marked after the receipt of the first dose. This finding would support efforts to maximize vaccine uptake with two doses among vulnerable populations. (Funded by Public Health England.)
n engl j med nejm.org
The New England Journal of Medicine
Downloaded from nejm.org on July 31, 2021. For personal use only. No other uses withou